Skip to main content
Premium Trial:

Request an Annual Quote

Sense Biodetection Strikes European Distribution Deal for Point-of-Care COVID-19 Test

NEW YORK — Sense Biodetection said on Thursday that it has struck a distribution deal for its Veros COVID-19 point-of-care test covering several European markets.

The single-use test uses a proprietary enzymatic nucleic acid amplification chemistry that does not require an instrument and returns results in 15 minutes, according to the UK-based company. It was CE marked earlier this year.

Under the terms of the distribution deal, Sissach, Switzerland-based Tecomedical will offer the test in Germany and Austria. Tecomedical will also distribute the test in Switzerland once it has received regulatory approval in that country.

Additional terms were not disclosed.

In March, Sense signed on Cruinn Diagnostics to distribute Veros COVID-19 in Ireland.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.